About Athena

Athena Diagnostics is a reference laboratory dedicated to the development and commercialization of diagnostic testing for neurological disorders. Using innovative technologies, Athena provides neurologists and other physicians with diagnostic answers that can improve the quality of health care for patients in a cost effective manner.

Athena is a leading provider of advanced neurological, endocrine, and renal diagnostic assays. Our expertise includes diagnosis in the areas of: peripheral nerve disorders, neurogenetic disorders, Alzheimer’s disease, paraneoplastic syndromes, movement disorders, neuromuscular disorders, diabetes, kidney disease, and ataxia. Our technologies are licensed predominantly from the academic research environment and represent our commitment to cutting-edge technology and our close relationships with world-renowned experts in neurology and genetics. The technical staff at Athena Diagnostics performs over 200 assays for neurological diseases using a variety of sophisticated laboratory methods. Assays are performed in our laboratory located in Worcester, Massachusetts, and are available only to physicians.

Athena Diagnostics began its services to neurologists as Genica Pharmaceuticals Corporation in 1989 by offering a service to diagnose Duchenne Muscular Dystrophy. In 1995, Genica was acquired by Athena Neurosciences, Inc., a research-based pharmaceutical company committed to the field of neurology. In 1996 Athena Neurosciences, together with Athena Diagnostics, was acquired by Elan Corporation, plc. In 2002, Athena was purchased by Behrman Capital, a private equity investment firm with a long history of successful investments in the clinical laboratory sector.

In March 2006, Athena was acquired by Fisher Scientific International, which itself merged with Thermo Electron Corporation in November 2006 to form Thermo Fisher Scientific, the world leader in serving science with instruments, equipment, reagents, consumables, software and services.